•  
• Tweet
•  
•        Print
•  
•         Track Keywords
•  
• 

Gregory Silberman B. G., Opalesque Geneva:

Because of the still illegal nature of cannabis, there hasn't been any major research done, except for those conducted in Israel. Apparently, American businesses and investors looking for advanced information on the plant are turning to the Jewish State, where the government not only allows research but funds it. And that's because American businesses and investors are starting to see the plant as a promising asset class.

Gregory Silberman, former director of alternative investments at Wilmington Trust and now CIO at Atlanta, Georgia-based ACG Wealth, is one of those investors. He believes we are going to find "amazing things about the plant going forward. People are going to realise it's a lot safer than some of the other drugs or treatments out there."

He goes on to give what he calls a bold prediction: "the pendulum is going to swing all the way from what is an uber-illegal substance to the point where there will be government-sponsored programmes, where the government will actually dispense cannabis as an antidote against opioids addictions. I suspect that cannabis could also be used to treat people against alcohol addiction and perhaps even nicotine addiction." Hopefully, his cannabis-related investments will have d......................

To view our full article Click here